Collaboration Agreement for Patient-Centric CAR-T Service

This document is a collaboration agreement outlining a project between Gilead Sciences Ltd and Western General Hospital aimed at initiating a patient-centric Chimeric Antigen Receptor T Cell (CAR-T) service. The project addresses unmet needs in the treatment of Non-Hodgkin’s Lymphoma (NHL) patients, particularly in the context of NHS clinics facing resource constraints. It identifies key issues such as the lack of consistent communication and education for healthcare professionals, which can lead to inefficiencies in patient management. The project aims to establish dedicated resources for a period of 24 months to enhance the CAR-T treatment pathway, improve patient experiences, and facilitate better coordination among multidisciplinary teams. Specific objectives include setting up a joint nurse/pharmacy clinic, enhancing education for stakeholders, and implementing a holistic needs assessment approach. Expected benefits include improved patient support throughout the treatment pathway, more efficient resource use within the NHS, and strengthened collaboration between Gilead and NHS entities.